Re: Gerhardt Attard, Neeraj Agarwal, Julie Graff, et al. Niraparib plus Abiraterone Acetate and Prednisone for HRR-mutated Metastatic Castration-sensitive Prostate Cancer: Results from the AMPLITUDE Phase 3 Trial. J Clin Oncol 2025;43(17 Suppl):LBA5006

Affiliations

• ¹ Oncology Unit, Andrea Tortora Hospital, ASL Salerno, Pagani, Italy; Associazione Oncologia Ricerca Assistenza ETS, Salerno, Italy; Saint Camillus International University of Health Sciences, Rome, Italy. Electronic address: direttoreuocpagani@gmail.com.
• ² Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Laboratory, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
• ³ Oncology Unit, Andrea Tortora Hospital, ASL Salerno, Pagani, Italy; Associazione Oncologia Ricerca Assistenza ETS, Salerno, Italy.